Leadership Team

Dr. Hixson serves as the company's chief executive officer. Dr. Hixson has served as chairman of the board of directors since 2003. He also currently serves on the board of directors of BrainCells, Inc., a biopharmaceutical company focused on central nervous system drug development, where he was chief executive officer from July 2004 until September 2005.

Allan T. Bombard, M.D. is chief medical officer, Sequenom, Inc. as well as clinical professor, obstetrics and gynecology, Albert Einstein College of Medicine.

Dr. Cantor joined the company as chief scientific officer. He was previously the chair and professor of the department of biomedical engineering and biophysics, and director of the Center for Advanced Biotechnology at Boston University.

Mr. Maier serves as Sequenom's chief financial officer. Mr. Maier served as senior vice president and chief financial officer of Ligand Pharmaceuticals Incorporated from 1992 until January 2007, where he helped build Ligand from a venture stage company to a commercial, integrated biopharmaceutical organization.

Dr. Lindsay serves as Sequenom's executive vice president of research and development. Dr. Lindsay has been a director since 2003.

Mr. Michael Monko joined Sequenom in August 2006. Mr. Monko has 20 years of life science sales and marketing experience. He served as vice president of sales for Upstate/Chemicon with global sales and management responsibility for more than 100 sales, service and support employees.

Ms. Alisa Judge brings over 20 years of human resources experience having previously served as vice president of human resources at Claritas, a division of the Nielsen Company, the world's leading provider of marketing information and audience measurement, prior to Claritas, Ms. Judge held the same role for GKN Aerospace Chem-tronics, a leading global supplier to the world's automotive and aerospace manufacturers.

Shawn M. Marcell serves as vice president of molecular diagnostics at Sequenom. Shawn joined Sequenom in 2008, through the acquisition of SensiGen, where he served as president and CEO.

Mr. Larry Myres has over 20 years of experience in medical device operations. Prior to joining Sequenom, Mr. Myres was vice president of operations for medical device companies DexCom, Inc. and Precision Vascular Systems.

Mr.Neumann has served as Vice-President & General Counsel and Assistant Secretary for the Company since 2001. Mr. Neumann joined the Company in 1999 as Corporate Counsel.